Astellas Pharma (OTCMKTS:ALPMY – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.09), MarketWatch Earnings reports. Astellas Pharma had a net margin of 6.27% and a return on equity of 12.77%. Astellas Pharma Stock Down 1.1 […]
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $15.72 and traded as low as $14.49. Astellas Pharma shares last traded at $14.55, with a volume of 144,614 shares. Analyst Ratings Changes Separately, […]
Astellas Pharma Inc. (OTCMKTS:ALPMY – Free Report) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 40,900 shares, a drop of 32.2% from the May 31st total of 60,300 shares. Based on an average daily trading volume, of 89,800 shares, […]
Astellas Pharma (OTCMKTS:ALPMY – Get Rating) and Thorne HealthTech (NASDAQ:THRN – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Analyst Ratings This is a summary of recent recommendations and […]
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 3,300 shares, a drop of 85.3% from the May 15th total of 22,400 shares. Based on an average daily volume of 136,900 shares, the […]